| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/978-1-4419-0981-7_14 |
| P698 | PubMed publication ID | 20204764 |
| P50 | author | Pierre Van Damme | Q64500305 |
| P2093 | author name string | Daniel Shouval | |
| Koen Van Herck | |||
| Alessandro R Zanetti | |||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis B | Q6853 |
| Hepatitis B virus | Q6844 | ||
| P1104 | number of pages | 14 | |
| P304 | page(s) | 175-188 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Advances in Experimental Medicine and Biology | Q4686385 |
| P1476 | title | Strategies for global prevention of hepatitis B virus infection | |
| P478 | volume | 659 |
| Q35507167 | A comparison of treatment with adefovir and entecavir for chronic hepatitis B in China: The 2-year results of a prospective study: Adefovir versus Entercavir for Chronic Hepatitis B. |
| Q39653215 | Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV |
| Q35950941 | High hepatitis B virus load is associated with hepatocellular carcinomas development in Chinese chronic hepatitis B patients: a case control study |
| Q35183285 | Lamivudine plus adefovir is a good option for chronic hepatitis B patients with viral relapse after cessation of lamivudine treatment |
| Q33780105 | Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions |
| Q57929322 | Nucleoside Analog-treated Chronic Hepatitis B Patients showed Reduced Expression of PECAM-1 Gene in Peripheral Blood Mononuclear Cells in Bangladesh |
| Q37488838 | Performance evaluation of the HepB Typer-Entecavir kit for detection of entecavir resistance mutations in chronic hepatitis B. |
Search more.